Annual report pursuant to Section 13 and 15(d)

Supplemental Disclosure of Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details)

v3.20.1
Supplemental Disclosure of Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Jun. 02, 2018
Cash paid for interest $ 313,918  
Cash paid for income taxes 45,000 23,362  
Property and equipment     $ 7,100,000
Common stock issued for conversion of Series I-2 Preferred Stock 1,268,972 1,513,105  
Exchange of debentures for Series I-2 Preferred Stock 1,420  
Series J Preferred Stock issued in exchange for notes payable and accrued expenses 250,000  
Issuance of Series K Preferred Stock 2,500  
Exchange of Series J Preferred Stock for Series K Preferred Stock (2,500)  
Common stock issued in cashless exercise of warrants 11,962 4,619,150  
Conversion of Series H Preferred Stock 50,000  
Debentures converted into common stock 8,128,044  
Original issue discounts of debentures and notes payable 400,000 2,160,000  
Deemed dividend for trigger of down round provision feature 123,861,587 231,843,826  
Acquisitions of Hospitals and Medical Center [Member]      
Cash 375  
Inventory 317,427 450,682  
Prepaid and other current assets 310,385  
Property and equipment 500,000 7,129,484  
Intangible assets 250,000 504,806  
Accrued expenses $ 158,890 $ (193,966)